Trade 337

HOLD ANET

0 shares at $141.71 on 2026-05-06

Reasoning

ANET post-earnings selloff to $141.81 (-15.4%) presents an attractive risk/reward on valuation, but Rule 33 (averaging down constraint) is not fully satisfied. The playbook thesis cites supply constraints and profit-taking as drivers, but supply constraint is a fundamental deterioration signal, not a temporary catalyst like sympathy sell or sector contagion. Current position is 1.40 shares (~$198.53, 2.5% of portfolio). Adding to target 2.5% would cost ~$0, but the invalidation level for the thesis (below $130 per risk_notes) is only ~8% below current price — tight margin. Rule 33 requires: (1) named catalyst distinct from fundamental deterioration, (2) defined invalidation level with auto-exit trigger, (3) post-add exposure ≤10%. The supply constraint warning fails criterion (1) — it is fundamental risk, not a temporary dip. Downgrade to HOLD-review pending clearer catalyst confirmation or technical stabilization above $145.

Thesis

ANET enters the post-NVDA inflection point. Semis rallied strongly today (AMD +7.4%, INTC +6.7%) ahead of NVDA earnings AMC. ANET is AI networking-adjacent and remains our highest-risk position at ~11% below cost basis. The NVDA earnings result tonight will determine whether this thesis survives. If NVDA beats and raises guidance confirming sustained hyperscaler capex, ANET should re-rate toward $155-160. If NVDA disappoints, the $125 invalidation level becomes critical. The broad semi rally today is encouraging but could reverse if NVDA guidance disappoints. (long, medium confidence)

Cited evidence

News

Macro